|
|
|
|
Beijing Lunarsun Pharmaceutical Co. Ltd. |
• Company brief:
• Beijing Lunarsun Pharmaceutical Co., Ltd is a professional pharmaceutical company. It integrates R&D, manufacturing, marketing and distribution as a whole. We concentrates on R&D, manufacture, marketing and sale of APIs and Pharmaceutical intermediates. And foreign trade of pharmaceutical APIs and intermediates.
• In APIs, the key products are anti-neoplastic products and medicine for treatment of hepatitis B; most of the products comply with ICH requirements. The in-house standard meets or even surpasses the requirements of CP, USP and EP, etc. We also possess the ability of researching and developing new medicines, large-scale production and normalized quality analysis. Moreover, we have a professional team to manage DMF documents and certification. Currently, DMF document for Bisoprolol Fumarate Documents for Temozolomide, Fludarabine Phosphate and Voriconazole are under proceeding. With accumulated efforts and experience for years, our company has already formed stronger brand competitiveness in pharmaceutical industry.
• BUSINESS SCOPE
• R&D, registration, production and sales of chemical APIs;
• International purchase and sales of chemical APIs;
• Registration and certification of APIs in foreign countries;
• To be agent of foreign suppliers and help them manage the registration and sales of APIs;
• To be agent of Chinese suppliers and help them manage the registration and sales of formulations.
|
Key Products/Services:
Adefovir dipivoxil,Amisulpride,Fludarabine phosphate,Voriconazole,Temozolomide,Vecurouniu Bromide,Bisoprolol Fumarate,Gemcitabine intermediates,Docetaxel,Hydroxyethyl starch 130/0.4
|
Category:
Pharmaceutical Chemicals |
Business Type:
Manufacturer
|
Annual Sales Range:
US$10 Million - US$50 Million |
Legal Representative/CEO:
|
Year Established:
|
Number of Employees:
51 - 100 People
|
GMPS:
Unrevealed |
|
|
|
|
|
|
